Abstract

Background and aimsWe aimed to validate a nurse-led process using electronic health records to identify those at risk of familial hypercholesterolaemia (FH) for genetic diagnosis in primary care. MethodsThose at risk of FH were identified using searches developed and refined locally and implemented in primary care by a trained nurse; they were invited for further assessment and genetic testing if indicated. Family members at risk of FH were identified and invited for cascade testing. ResultsIn total 94,444 patient records were screened (expected prevalence of FH (1 in 250); 377). Of 176 records which already had a diagnostic for FH, 15 had been genetically confirmed and one was undergoing DNA testing. A further 572 (0.61%) were identified as high risk of FH. After desktop screening, 113 (15%) were invited for further assessment. Of these, 73 individuals attended the primary care clinic (64%) of whom 61 (54%) underwent proband genetic testing. Pathogenic variants were detected in 22 cases (36%) and variants of unknown significance in a further 4 cases; a total of 26 probands (43%) were therefore referred for family cascade testing. ConclusionsAn optimised FH identification pathway, based on the NICE CG71 recommendations for systematic searching of primary care electronic health records, can be deployed successfully in primary care settings.

Highlights

  • Cardiovascular disease (CVD) is the leading cause of death world­ wide, accounting for 31% of all global deaths [1]

  • After exclusion of 84 patients with hypercholesterolaemia due to other causes or who were otherwise considered unsuitable on nurse-led desk top review of the patient records, 43 potentially eligible patients ranked highest with estimated Dutch Lipid Clinic Network score were invited for screening and 21 (49%) attended the outreach familial hypercholesterolaemia (FH) clinic

  • Of 11 patients with completed tests, 8 patients received a negative result, Variants of Un­ certain Significance (VUS) were identified in 2 patients and a pathogenic variant was identified in 1 patient

Read more

Summary

Introduction

Cardiovascular disease (CVD) is the leading cause of death world­ wide, accounting for 31% of all global deaths [1]. An important under-diagnosed cause of premature CVD, coronary heart disease (CHD), is familial hypercholesterolaemia (FH) [2,3]. As many as 250,000 people in the UK may be living with the con­ dition, but it is estimated that only around 15,000 patients have a formal genetic diagnosis of FH [3,8]. We aimed to validate a nurse-led process using electronic health records to identify those at risk of familial hypercholesterolaemia (FH) for genetic diagnosis in primary care. Methods: Those at risk of FH were identified using searches developed and refined locally and implemented in primary care by a trained nurse; they were invited for further assessment and genetic testing if indicated. Members at risk of FH were identified and invited for cascade testing. Results: In total 94,444 patient records were screened (expected prevalence of FH (1 in 250); 377). Conclusions: An optimised FH identification pathway, based on the NICE CG71 recommendations for systematic searching of primary care electronic health records, can be deployed successfully in primary care settings

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.